Energenesis Biomedical CO.,LTD. (TWSE: 6657)
Health Care · Biotechnology · TW
NT$30.60
-0.16% today · -49.0% 1Y
Energenesis Biomedical CO.,LTD. (TWSE: 6657) operates in the Biotechnology industry within the Health Care sector. The company is valued at $84.48M and employs 35 people.
Over the last twelve months the share price has lost 49.0%, trading between 28.35 and 62.90.
Tweenvest scores Energenesis Biomedical CO.,LTD. across four factors: quality 39/100, value 34/100, growth 20/100. Its strongest factor is quality.
6657 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $84.48M
- Revenue (TTM)
- $240.14K
- P/E
- —
- EPS
- -3.38
- Dividend yield
- —
- Beta (5Y)
- 0.43
- 52-week high
- NT$62.90
- 52-week low
- NT$28.35
- Avg volume (3M)
- —
- Shares outstanding
- 87.91M
- Employees
- 35
- Next earnings
- —
About Energenesis Biomedical CO.,LTD.
Energenesis Biomedical CO.,LTD., a firm established in 2012 and headquartered in Taipei, Taiwan, is an active participant in the biomedicine sector. The company specializes in the development of a diverse range of medical solutions and research materials. Its primary pharmaceutical pipeline includes ENERGI-F703, which is currently undergoing Phase II clinical trials for the treatment of diabetic foot ulcers, and ENERGI-F701, a topical solution for addressing alopecia that is also in its second phase of clinical assessment. The comprehensive portfolio of therapeutic agents further encompasses: ENERGI-F711, formulated as a cream for burns. ENERGI-F702, designed to combat metabolic diseases. ENERGI-F704, targeting inflammatory bowel disease. ENERGI-F708, for the management of asthma. ENERGI-F705, aimed at controlling Parkinson's disease. ENERGI-F707, addressing mitochondrial deficiencies. ENERGI-F706, used to treat cachexia. ENERGI-F709, which serves as a vaccine adjuvant. ENERGI-F710, intended for the regulation of blood phosphate levels. Beyond its therapeutic developments, Energenesis Biomedical also provides a selection of scientific research products, including reagents for Western blotting, cell culture supplements, components for protein isolation and quantification, various laboratory dyes, and buffer solutions.
- ISIN
- TW0006657000
- Founded
- 2012
- Listed since
- Jun 1, 2023
- Exchange
- Taiwan Stock Exchange
- Currency
- TWD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $265.55 | +0.22% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $440.98 | +0.38% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.44 | +0.22% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.78 | +0.13% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $825.89 | -0.98% |
| argenx SEENXTBR: ARGX | $65.85B | €864.20 | -4.19% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $137.91 | -4.94% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.